Target intelligence / Profile preview

Isocyanate-modified protein

Molecular classification
Other
01

Overview

Isocyanate-modified protein refers to proteins that have been covalently modified by isocyanate functional groups (–N=C=O), a highly reactive chemical group found in various industrial compounds—especially those used to make polyurethanes[1][3][6]. Isocyanates react primarily with nucleophilic amino acid side chains (notably the N-terminus and lysine residues), forming stable carbamate or urea linkages with the protein[3][4][6]. This process happens upon exposure to isocyanate-containing chemicals in occupational settings and is a key toxicological mechanism, as these protein modifications can elicit immune responses, leading to sensitization (such as occupational asthma and hypersensitivity pneumonitis)[3][6]. Isocyanate-protein adducts are used as biomarkers for occupational exposure and are a focus of analytical and immunological studies, but they are not conventional therapeutic targets.

Other names
Isocyanate-protein adductProtein isocyanate conjugateIsocyanate-protein conjugateProtein-NCO adduct
02

Mechanism of action

no drug mechanism; mechanism is covalent conjugation of isocyanate to protein nucleophiles

03

Biological functions

Othertargets protein structuremay alter protein functionsource of antigenicity
04

Disease associations

InflammationOccupational asthmaImmune responseOther
05

Safety considerations

Protein modification by isocyanates is associated with hypersensitivity reactions, allergic asthma, and possible immune responses[3][6]
06

Biomarkers

Isocyanate-protein adducts (e.g., albumin isocyanate adduct) used as biomarkers for isocyanate exposure[6]

Beyond the preview

Go deeper on Isocyanate-modified protein.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Isocyanate-modified protein.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call